Home Data Calendar Blog

PYXS

Tables

		2024-03-31
Common Stock Value		0.06
Weighted Average Number Of Diluted Shares Outstanding		51.29
Weighted Average Number Of Shares Outstanding Basic		51.29
Earnings Per Share Basic		-0.06
Earnings Per Share Diluted		-0.06

		2024-03-31
Revenues		16.15
Cost Of Revenue		0.47
Operating Expenses		NA
Research And Development Expense		13.03
General And Administrative Expense		8.25
Operating Income Loss		-5.61
Allocated Share Based Compensation Expense		4.32
Income Taxes Paid		NA
Profit Loss		-3.26
Other Comprehensive Income Loss Net Of Tax		-0.12
Net Income Loss		-3.26
Comprehensive Income Net Of Tax		-3.38

		2024-03-31
Assets		220.22
Liabilities		36.06
Liabilities And Stockholders Equity		220.22
Stockholders Equity		184.16

		2024-03-31
Assets Current		172.38
Cash And Cash Equivalents At Carrying Value		27.97
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		29.44
Marketable Securities Current		129.06
Accounts Receivable Net Current		8.00
Other Assets Current		NA
Prepaid Expense And Other Assets Current		NA

		2024-03-31
Property Plant And Equipment Gross		NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		NA
Property Plant And Equipment Net		11.33
Intangible Assets Net Excluding Goodwill		23.73
Finite Lived Intangible Assets Net		NA

		2024-03-31
Liabilities Current		14.14
Accounts Payable Current		2.29
Other Accrued Liabilities Current		NA
Accrued Liabilities Current		10.83
Contract With Customer Liability Current		NA

		2024-03-31
Operating Lease Liability Noncurrent		19.76

		2024-03-31
Stockholders Equity		184.16
Common Stock Value		0.06
Additional Paid In Capital		473.64
Retained Earnings Accumulated Deficit		-289.48
Accumulated Other Comprehensive Income Loss Net Of Tax		-0.06
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		4.32

		2024-03-31
Net Cash Provided By Used In Operating Activities		-20.71
Net Cash Provided By Used In Investing Activities		-18.50
Net Cash Provided By Used In Financing Activities		57.51

		2024-03-31
Net Cash Provided By Used In Operating Activities		-20.71
Net Income Loss		-3.26
Profit Loss		-3.26
Depreciation Depletion And Amortization		1.12
Increase Decrease In Accounts Receivable		8.00
Increase Decrease In Accounts Payable		-1.36
Share Based Compensation		4.32

		2024-03-31
Net Cash Provided By Used In Investing Activities		-18.50
Payments To Acquire Property Plant And Equipment		0.24

		2024-03-31
Net Cash Provided By Used In Financing Activities		57.51

		2024-03-31
Revenues		16.15
Novartis, Sale Of Royalty Rights, Fourth Amendment Settlement Agreement And Royalty Purchase Agreement		8.00
Novartis, Royalty, Fourth Amendment Settlement Agreement And Royalty Purchase Agreement		8.10
Sale Of Royalty Rights		8.00
Royalty		8.15

Plots across concepts

Line plots across dimensions of each concept